Novel Therapeutic Rationale for Targeting HDAC1 and PIM2 in Multiple Myeloma

被引：0
|
作者：
Harada, Takeshi [1 ]
Oda, Asuka [1 ]
Ohguchi, Hiroto [2 ]
Grondin, Yohann [3 ]
Tenshin, Hirofumi [4 ]
Hiasa, Masahiro [4 ]
Teramachi, Jumpei [5 ]
Oura, Masahiro [1 ]
Sogabe, Kimiko [1 ]
Fujii, Shiro [1 ]
Nakamura, Shingen [1 ]
Miki, Hirokazu [6 ]
Kagawa, Kumiko [1 ]
Ozaki, Shuji [7 ]
Hideshima, Teru [8 ]
Anderson, Kenneth C. [8 ]
Abe, Masahiro [1 ]
机构：
[1] Tokushima Univ, Inst Biomed Sci, Dept Hematol Endocrinol & Metab, Grad Sch, Tokushima, Japan
[2] Kumamoto Univ, Div Dis Epigenet, IRDA, Kumamoto, Japan
[3] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA USA
[4] Tokushima Univ, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Grad Sch, Tokushima, Japan
[5] Tokushima Univ, Inst Biomed Sci, Dept Tissue Regenerat, Grad Sch, Tokushima, Japan
[6] Tokushima Univ Hosp, Div Transfus Med & Cell Therapy, Tokushima, Japan
[7] Tokushima Prefectural Cent Hosp, Dept Hematol, Tokushima, Japan
[8] Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3111
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Targeting CD47 As a Novel Therapeutic Strategy in Multiple Myeloma
    Muz, Barbara
    Kusdono, Hubert D.
    King, Justin
    Kohnen, Daniel
    Fiala, Mark A.
    Vij, Ravi
    Capoccia, Ben
    Manning, Pamela T.
    Salama, Noha Nabil
    Azab, Abdel Kareem
    BLOOD, 2017, 130
  • [42] Targeting Tryptophan Metabolism in Multiple Myeloma Offers Novel Therapeutic Approach
    Reinke, Julia Grace
    Chaudhry, Kanita
    Carlson, Louise
    Peng, Peng
    Petrusca, Daniela
    Schorr, Christopher
    Lee, Kelvin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S197 - S197
  • [43] The role of PIM1/PIM2 kinases in tumors of the male reproductive system
    Pedro Jimenez-Garcia, Manuel
    Lucena-Cacace, Antonio
    Jose Robles-Frias, Maria
    Narlik-Grassow, Maja
    Blanco-Aparicio, Carmen
    Carnero, Amancio
    SCIENTIFIC REPORTS, 2016, 6
  • [44] Differential HDAC1/2 network analysis reveals a role for prefoldin/CCT in HDAC1/2 complex assembly
    Banks, Charles A. S.
    Miah, Sayem
    Adams, Mark K.
    Eubanks, Cassandra G.
    Thornton, Janet L.
    Florens, Laurence
    Washburn, Michael P.
    SCIENTIFIC REPORTS, 2018, 8
  • [45] Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
    Amodio, Nicola
    Stamato, Maria Angelica
    Guila, Anna Maria
    Morelli, Eugenio
    Romeo, Enrica
    Raimondi, Lavinia
    Pitari, Maria Rita
    Ferrandino, Ida
    Misso, Gabriella
    Caraglia, Michele
    Perrotta, Ida
    Neri, Antonino
    Fulciniti, Mariateresa
    Rolfo, Christian
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (06) : 1364 - 1375
  • [46] Prolonged histone hyperacetylation with a novel class of HDAC1/2 selective inhibitors
    Methot, Joey L.
    Chenard, Melissa
    Joshua, Close
    Jonathan, Cruz
    Dahlberg, William
    Fleming, Judith
    Hamblett, Chris
    Julie, Hamill
    Harrington, Paul
    Harsch, Andreas
    Heidebrecht, Richard
    Hughes, Bethany
    Jung, Joon
    Kenific, Candia
    Kral, Astrid
    Middleton, Richard
    Ozerova, Nicole
    Sloman, David
    Stanton, Matthew
    Szewczak, Alexander
    Wilson, Kevin
    Witter, David
    Secrist, Paul
    Miller, Thomas
    CANCER RESEARCH, 2010, 70
  • [47] Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex
    Wiper-Bergeron, N
    Wu, DM
    Pope, L
    Schild-Poulter, C
    Haché, RJG
    EMBO JOURNAL, 2003, 22 (09): : 2135 - 2145
  • [48] Targeting Pim2 improves effector function and longevity of T cells in cancer immunotherapy
    Wu, Yongxia
    Tian, Linlu
    Hitchingham, Brianna
    Choi, Heejin
    Yang, Kaipo
    Yu, Xue-Zhong
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [49] HDAC11 Is a Candidate Therapeutic Target in Multiple Myeloma
    Brayer, Jason B.
    Distler, Allison
    Meads, Mark B.
    Sahakian, Eva
    Powers, John J.
    Nguyen, Tuan
    Alsina, Melissa
    Nishihori, Taiga
    Baz, Rachid
    Pinilla-Ibarz, Javier
    Sotomayor, Eduardo Martin
    Shain, Ken H.
    BLOOD, 2017, 130
  • [50] Dysfunctional HDAC8 Impacts Genomic Integrity and Is a Novel Therapeutic Target in Multiple Myeloma
    Chyra, Zuzana
    Talluri, Srikanth
    Prabhala, Rao
    Samur, Mehmet K.
    Aktas-Samur, Anil
    Xu, Yan
    Beeler, Aaron B.
    Hajek, Roman
    Fulciniti, Mariateresa
    Shammas, Masood A.
    Munshi, Nikhil C.
    BLOOD, 2021, 138
12345